SAMUEL NEMATI: Open Payments
NPI 1275299661 · KILGORE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$343 in 20 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $176 · 2025 $343
Food & beverage: $343
| Company | Payments | Amount |
|---|---|---|
| Forte Bio-Pharma LLC | 9 | $149 |
| GlaxoSmithKline, LLC. | 3 | $49 |
| Amgen Inc. | 2 | $43 |
| Novo Nordisk Inc | 2 | $35 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| PFIZER INC. | 1 | $14 |
| Esperion Therapeutics, Inc. | 1 | $14 |
Products named: PROLATE, TRELEGY ELLIPTA, OTEZLA, Rybelsus, GEMTESA, Kerendia, TANLOR, ELIQUIS.
Industry payments across TX — which companies pay providers there.
